California Medical Association
CMA Member Help Center
Diabetes remains one of California’s fastest-growing and most costly diseases. An estimated 2.5 million California adults have been diagnosed with diabetes and 13 million – nearly half of the state’s adult population – have prediabetes, increasing their risk of developing diabetes over the next few years. While the prevalence of prediabetes increases with age, one out of every three Californians between the age of 18 and 39 is estimated to have prediabetes. Rates of prediabetes also vary across racial groups, with Pacific Islanders, Native American, and African American communities experiencing heightened risks.
Prediabetes is a condition in which blood glucose or hemoglobin A1C (HbA1C) levels are higher than normal, but not high enough yet to be diagnosed as type 2 diabetes. Among prediabetes patients, up to 30 percent are expected to develop diabetes within five years, and up to 70 percent are expected to develop the disease in their lifetime. Fortunately, prediabetes can be reversed, and the sooner patients find out they have prediabetes, the better their chances of preventing the onset of type 2 diabetes. The National Diabetes Prevention Program is a Centers for Disease Control and Prevention (CDC)-recognized evidence-based lifestyle change program for persons with prediabetes that has been demonstrated to prevent or delay the development of diabetes.
The California Medical Association (CMA) has partnered with the American Medical Association (AMA) to raise awareness of prediabetes resources, help providers connect their patients to CDC-recognized Diabetes Prevention Programs, and allow patients to take charge of their health. This webinar will describe the clinical practice burden and trends in prediabetes and type 2 diabetes in California; review the evidence that supports systematically screening patients for prediabetes and referring to a community based program, like the National Diabetes Prevention Program; and recognize the tools available to identify patients with prediabetes and establish a referral process.
This webinar is free to all attendees.
(from left to right)
Jessica Núñez de Ybarra, M.D., MPH, FACPM, is board certified in public health and general preventive medicine and a fellow of the American College of Preventive Medicine. She serves as the Chronic Disease Control Branch Chief in for CDPH as a Public Health Medical Administrator I. She has a variety of experience working with teams, partners and stakeholders in disease prevention, promoting health equity and team-based care, among other health related topics.
Kate Kirley, M.D., M.S., is the director of chronic disease prevention in AMA’s Improving Health Outcomes group. Prior to joining AMA, she was a practicing family physician and health services researcher at NorthShore University HealthSystem, as well as a clinical assistant professor in the Department of Family Medicine at the University of Chicago.
Janet Williams is the senior program manager for AMA’s Improving Health Outcomes group. She is responsible for AMA’s work on bridging the gap between clinical care and community resources to improve health outcomes. She manages AMA’s prediabetes initiative with the YMCA of the USA. She also leads a team that, along with the CDC, analyzes and develops clinical tools and resources for engaging health systems, clinicians and health departments in diabetes prevention.
Webinar Notice: Please register at least one hour before the webinar. If you do not register an hour before the webinar start time, we cannot guarantee your attendance. Questions: 800-786-4CMA (4262)